These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18420834)

  • 1. Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction.
    Dawn B; Tiwari S; Kucia MJ; Zuba-Surma EK; Guo Y; Sanganalmath SK; Abdel-Latif A; Hunt G; Vincent RJ; Taher H; Reed NJ; Ratajczak MZ; Bolli R
    Stem Cells; 2008 Jun; 26(6):1646-55. PubMed ID: 18420834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction.
    Zuba-Surma EK; Guo Y; Taher H; Sanganalmath SK; Hunt G; Vincent RJ; Kucia M; Abdel-Latif A; Tang XL; Ratajczak MZ; Dawn B; Bolli R
    J Cell Mol Med; 2011 Jun; 15(6):1319-28. PubMed ID: 20629987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction.
    Zuba-Surma EK; Kucia M; Dawn B; Guo Y; Ratajczak MZ; Bolli R
    J Mol Cell Cardiol; 2008 May; 44(5):865-73. PubMed ID: 18430437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of Human Umbilical Cord Blood-Derived Cellular Fraction Improves Left Ventricular Function and Remodeling After Myocardial Ischemia/Reperfusion.
    Zhao L; Cheng G; Choksi K; Samanta A; Girgis M; Soder R; Vincent RJ; Wulser M; De Ruyter M; McEnulty P; Hauptman J; Yang Y; Weiner CP; Dawn B
    Circ Res; 2019 Sep; 125(8):759-772. PubMed ID: 31462157
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and Characterization of Lineage(-)CD45(-)Sca-1(+) VSEL Phenotypic Cells Residing in Adult Mouse Bone Tissue.
    Nakatsuka R; Iwaki R; Matsuoka Y; Sumide K; Kawamura H; Fujioka T; Sasaki Y; Uemura Y; Asano H; Kwon AH; Sonoda Y
    Stem Cells Dev; 2016 Jan; 25(1):27-42. PubMed ID: 26595762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine bone marrow Lin⁻Sca⁻1⁺CD45⁻ very small embryonic-like (VSEL) cells are heterogeneous population lacking Oct-4A expression.
    Szade K; Bukowska-Strakova K; Nowak WN; Szade A; Kachamakova-Trojanowska N; Zukowska M; Jozkowicz A; Dulak J
    PLoS One; 2013; 8(5):e63329. PubMed ID: 23696815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling.
    Singla DK; Lyons GE; Kamp TJ
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1308-14. PubMed ID: 17416601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
    Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very small embryonic-like stem cells in cardiovascular repair.
    Wojakowski W; Kucia M; Zuba-Surma E; Jadczyk T; Książek B; Ratajczak MZ; Tendera M
    Pharmacol Ther; 2011 Jan; 129(1):21-8. PubMed ID: 20971132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction.
    Wojakowski W; Tendera M; Kucia M; Zuba-Surma E; Paczkowska E; Ciosek J; Hałasa M; Król M; Kazmierski M; Buszman P; Ochała A; Ratajczak J; Machaliński B; Ratajczak MZ
    J Am Coll Cardiol; 2009 Jan; 53(1):1-9. PubMed ID: 19118716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
    Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
    Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms.
    Duran JM; Makarewich CA; Sharp TE; Starosta T; Zhu F; Hoffman NE; Chiba Y; Madesh M; Berretta RM; Kubo H; Houser SR
    Circ Res; 2013 Aug; 113(5):539-52. PubMed ID: 23801066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function.
    Dawn B; Guo Y; Rezazadeh A; Huang Y; Stein AB; Hunt G; Tiwari S; Varma J; Gu Y; Prabhu SD; Kajstura J; Anversa P; Ildstad ST; Bolli R
    Circ Res; 2006 Apr; 98(8):1098-105. PubMed ID: 16556872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilization of very small embryonic-like stem cells in acute coronary syndromes and stroke.
    Wojakowski W; Ratajczak MZ; Tendera M
    Herz; 2010 Oct; 35(7):467-72. PubMed ID: 20981396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells.
    Shaikh A; Bhartiya D; Kapoor S; Nimkar H
    Stem Cell Res Ther; 2016 Apr; 7(1):59. PubMed ID: 27095238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
    Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction.
    Zhao TC; Tseng A; Yano N; Tseng Y; Davol PA; Lee RJ; Lum LG; Padbury JF
    J Appl Physiol (1985); 2008 Jun; 104(6):1793-800. PubMed ID: 18292296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium.
    Liao SY; Liu Y; Siu CW; Zhang Y; Lai WH; Au KW; Lee YK; Chan YC; Yip PM; Wu EX; Wu Y; Lau CP; Li RA; Tse HF
    Heart Rhythm; 2010 Dec; 7(12):1852-9. PubMed ID: 20833268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
    Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin administration does not improve the mobilization of very small embryonic-like stem cells (VSELs) in contrast to resveratrol treatment in a murine model of acute myocardial infarction.
    Wang H; Yang YJ; Qian HY; Zhang Q; Gao LJ; Li P; Wang TJ; Wang SD
    Physiol Res; 2012; 61(5):543-9. PubMed ID: 23240923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.